ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Pepperstone

Trade Now

Pepperstone
Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
S&P ASX 200
7,629.00
0.55%
S&P ASX All Technology
3,016.30
1.48%
Brent Oil
83.54
-0.11%
US Dollar vs AUD
1.51906
-0.18%
Bitcoin
59,495.91
0.63%
Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. Incannex Healthcare Ltd (IXHL)

  7. Incannex Healthcare Ltd (IXHL) News

IXHL Incannex Healthcare Ltd

2.55
0.00 (0.00%)
Pre Market
Last Updated: 18:25:25
Delayed by 15 minutes
Share Name Share Symbol Market Stock Type
Incannex Healthcare Ltd IXHL NASDAQ Common Stock
  Price Change Price Change % Share Price Last Trade
Upgrade Icon
0.00 0.00% 2.55 18:25:25
Open Price Low Price High Price Close Price Previous Close
2.55
more quote information »

Recent News

Date Time Source Heading
16/4/202422:00GLOBEIncannex Healthcare Inc. Quarterly Update, Q1 2024
28/2/202423:30GLOBEIncannex Announces Positive Topline Results from Phase 2..
17/2/202400:00EDGAR2Form 8-K - Current report
16/2/202423:30GLOBEIncannex Completes Successful Pre-IND Meeting with the FDA..
14/2/202422:16EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
01/2/202423:30EDGAR2Form 8-K - Current report
01/2/202423:30GLOBEClarion Clinics Open for Psychedelic-Assisted Treatments
25/1/202408:30EDGAR2Form 8-K - Current report
25/1/202408:05GLOBEIncannex Commences Dosing in Phase 2 Clinical Trial..
19/1/202401:08EDGAR2Form 8-K - Current report
19/1/202400:22GLOBEIncannex Completes Dosing and Therapy in Phase 2 “PsiGAD”..
17/1/202423:30GLOBEIncannex Receives IRB Approval for the RePOSA Phase 2/3..
17/1/202422:05EDGAR2Form 8-K - Current report
22/12/202322:07EDGAR2Form 8-K - Current report
22/12/202312:54EDGAR2Form 4 - Statement of changes in beneficial ownership of..
22/12/202312:53EDGAR2Form 4 - Statement of changes in beneficial ownership of..
22/12/202312:50EDGAR2Form 4 - Statement of changes in beneficial ownership of..
22/12/202312:47EDGAR2Form 4 - Statement of changes in beneficial ownership of..
22/12/202308:05GLOBEClarion Clinics Receives Ethics Board Endorsement for the..
21/12/202309:05EDGAR2Form S-8 - Securities to be offered to employees in employee..
06/12/202323:30GLOBEIncannex Update on IHL-42X Drug Candidate in Phase 2/3..
30/11/202305:40GLOBEIncannex Healthcare Announces Completion of..
17/11/202301:38EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
17/11/202300:30GLOBEFederal Court of Australia Approves Incannex’s..
08/11/202322:07EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
26/10/202321:02EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
08/9/202321:30GLOBEIncannex Announces Participation at the H.C. Wainwright 25th..
08/9/202320:03EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
01/9/202322:43EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
24/8/202321:30GLOBEIncannex to Prepare FDA IND Application for..
22/8/202321:30GLOBEReview of IND Application for IHL-42X by US FDA has been..
08/8/202322:00GLOBEClarion Clinics Begins Accepting Registrations for..
08/8/202320:02EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
28/7/202321:30GLOBEIncannex Healthcare June 2023 Quarterly Activities Report..
26/7/202321:30GLOBEIncannex Completes Positive Pre-IND Meeting with US FDA on..
21/7/202323:09GLOBEIncannex Submits IND Application to the US FDA for IHL-42X..
18/7/202321:40GLOBEIncannex engages Fortrea to Manage its FDA IND Opening Phase..
13/7/202322:00GLOBEIncannex Receives HREC Approval for Phase 2 Clinical Trial..
13/7/202320:02EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
10/7/202322:43EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
10/7/202321:30GLOBEIncannex Announces Intention to Redomicile to United States,..
06/7/202322:42GLOBEIncannex Receives Ethics Approval for..
23/6/202322:00GLOBEIncannex Announces Participation at the H.C. Wainwright 4th..
16/6/202322:00GLOBEIncannex Appoints Principal Investigators for IHL-42X Phase..
30/5/202322:00GLOBEWorld Renowned International Psychedelics Experts Join..
16/5/202321:50GLOBEIncannex Company Presentation – Presentation of Psychennex,..
05/5/202321:30GLOBEIncannex enters a lease for first psychedelic-assisted..

Your Recent History

NASDAQ
IXHL
Incannex Healthcare
Delayed Upgrade Clock
ADVFN Logo

Australia
Company
Business
Popular
Get The App

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved